Antioxidant cocktail may ease motor deficits in rett syndrome — a trial investigates

NCT ID NCT04041713

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This pilot study tests whether an antioxidant cocktail called Rett-T can improve motor function in children and adolescents with Rett syndrome, a rare genetic disorder that affects movement and coordination. Participants, aged 2 to 21 and at least partially able to walk, will receive either Rett-T or a placebo. The trial measures changes in motor skills and explores biological markers of safety and response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an antioxidant cocktail called Rett-T
What this could lead to
If effective, this antioxidant cocktail could offer a new way to ease motor difficulties in Rett syndrome, potentially improving daily function.
What could go wrong
This is a small early-stage pilot study, so results may not be conclusive. Antioxidants can interact with other medications, and benefits may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETT SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Holland Bloorview Kids Rehabilitation Hospital

    Toronto, Ontario, M4G 1R8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.